USPTO serial 76534186
TRUSTED PATHOLOGISTS. INVALUABLE ANSWERS.
Reviewed by CopyMark Law Group
Reg. 2957688Status 710
- Filing date
- Status date
- Registration date
- May 31, 2005
- Examiner
- CLAYTON, CHERYL A
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with TRUSTED PATHOLOGISTS. INVALUABLE ANSWERS.?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
SALT LAKE CITY, UT
Associated Regional and University Pathologists, Inc.
Salt Lake City, UT
Other trademarks owned by Associated Regional and University Pathologists, Inc.
Associated Regional and University Pathologists, Inc.
Salt Lake City, UT
Other trademarks owned by Associated Regional and University Pathologists, Inc.
Associated Regional and University Pathologists, Inc.
Salt Lake City, UT
Other trademarks owned by Associated Regional and University Pathologists, Inc.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lester K. Essig
LESTER K ESSIG RAY, QUINNEY & NEBEKERPO BOX 45385SALT LAKE CITY, UT 84145-0385UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 041 | educational services, namely arranging and conducting classes, seminars, conferences and workshops in the fields of pathology, clinical pathology, anatomic pathology, hematopathology, cytopathology, immunopathology, histopathology, disease pathology, infectious disease pathology, transplantation pathology, surgical pathology, autopsy pathology, cytology, flow cytometry, genetics, cytogenetics, gene identification, gene sequencing, gene therapy, molecular diagnostics, immunology, hematology, immunohematology, immunohistochemical staining, immunofluorescence, morphologic change, histology, microbiology, serology, clinical chemistry, oncology, virology, toxicology, microwave processing, microscopy, and electron microscopy | SECTION 8 - CANCELLED | Sep 30, 2003 |
| 042 | clinical laboratory services, reference laboratory services, dissection laboratory services, diagnostic laboratory services, medical laboratory services, and veterinary laboratory services, all in the fields of pathology, clinical pathology, anatomic pathology, hematopathology, cytopathology, immunopathology, histopathology, disease pathology, infectious disease pathology, transplantation pathology, surgical pathology, autopsy pathology, cytology, flow cytometry, genetics, cytogenetics, gene identification, gene sequencing, gene therapy, molecular diagnostics, immunology, hematology, immunohematology, immunohistochemical staining, immunofluorescence, morphologic change, histology, microbiology, serology, clinical chemistry, oncology, virology, toxicology, microwave processing, microscopy, and electron microscopy; and collecting, processing, treating, freezing, staining, dissecting, analyzing, screening, testing, typing and storing of biological substances and human and animal tissue, blood, blood components, cells, stems cells, abnormal cells, chromosomes and nucleic acid; providing information online over a global communications network and in printed materials in the fields of pathology, clinical pathology, anatomic pathology, hematopathology, cytopathology, immunopathology, histopathology, disease pathology, infectious disease pathology, transplantation pathology, surgical pathology, autopsy pathology, cytology, flow cytometry, genetics, cytogenetics, gene identification, gene sequencing, gene therapy, molecular diagnostics, immunology, hematology, immunohematology, immunohistochemical staining, immunofluorescence, morphologic change, histology, microbiology, serology, clinical chemistry, oncology, virology, toxicology, microwave processing, microscopy, and electron microscopy; medical research and testing services in the fields of pathology, clinical pathology, anatomic pathology, hematopathology, cytopathology, immunopathology, histopathology, disease pathology, infectious disease pathology, transplantation pathology, surgical pathology, autopsy pathology, cytology, flow cytometry, genetics, cytogenetics, gene identification, gene sequencing, gene therapy, molecular diagnostics, immunology, hematology, immunohematology, immunohistochemical staining, immunofluorescence, morphologic change, histology, microbiology, serology, clinical chemistry, oncology, virology, toxicology, microwave processing, microscopy, and electron microscopy | SECTION 8 - CANCELLED | Sep 30, 2003 |
| 044 | medical record keeping services, and medical patient reporting services | SECTION 8 - CANCELLED | Sep 30, 2003 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ARUP LABORATORIES, INC.
- Other trademarks owned by Associated Regional and University Pathologists, Inc.
- Other trademarks owned by Associated Regional and University Pathologists, Inc.
- Other trademarks owned by Associated Regional and University Pathologists, Inc.
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named TRUSTED PATHOLOGISTS. INVALUABLE ANSWERS.
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 20, 2013 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jan 6, 2012 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| May 31, 2005 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 19, 2005 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Jan 24, 2005 | ALIE | ASSIGNED TO LIE | — |
| Jan 18, 2005 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jan 18, 2005 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jan 6, 2005 | IUAF | USE AMENDMENT FILED | — |
| Jan 6, 2005 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jul 6, 2004 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 13, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 24, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 11, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 22, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 22, 2004 | PAPER RECEIVED | — | |
| Dec 15, 2003 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 14, 2003 | DOCK | ASSIGNED TO EXAMINER | — |